Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barré syndrome.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1866024.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In patients with Guillain-Barré syndrome (GBS) soluble interleukin-2 receptor (sIL-2R) levels were elevated compared with those of patients with other neurologic diseases (OND), and of healthy controls. Smaller increases in sIL-2R levels occurred in OND patients compared to healthy subjects. Monitoring of GBS patients clearly demonstrated that decreases in sIL-2R levels correlated with clinical recovery. Thus, T-cell activation may be relevant in the pathogenesis of GBS.
Medical subject headings
- Polyradiculoneuropathy
- Receptors, Interleukin-2